Bellevue (BBN.SW) traded up 0.61 % during a 24 hours period ending at 10:55 AM Central Europe on Wednesday 28th. One Bellevue stock can currently be bought for about CHF 6.64 on popular exchanges. Current supply of Bellevue stocks is 13.3 mn. Bellevue has a current market capitalization of CHF 89.3 mn and approximately CHF 36.6 k worth of Bellevue was traded on exchanges in the last 24 hours. Since last month end, Bellevue has traded -5.95 % down. Simple moving average of last 200 days is at CHF 8.08. The highest price of past 52 weeks was recorded at CHF 12.4 on 01/15/2026. 52 weeks low was at CHF 6.6 on 10/27/2026.

Summary of the latest news for Bellevue

The Swiss market index, the SPI, has shown steady gains on Tuesday, with the benchmark moving only marginally higher in the morning and settling near its daily high by mid‑afternoon. Analysts noted that the index’s performance over the year has been positive, reaching a new annual high earlier in the month. Within the SPI, Bellevue Group AG stands out for its dividend yield, which is projected to be the strongest among the constituents, according to recent FactSet estimates. In contrast, a review of an earlier investment in Bellevue shares revealed that a portfolio of shares bought a year ago would have declined in value, with the stock price falling by almost 22 percent over that period. The Bloomberg‑style snapshot shows Bellevue’s shares as a high‑yield option, while investors should remain aware of the broader market trend that has seen the index rise modestly throughout the year.

Here is how related stocks have performed in the past 24 hours:

  • Lastminute (LMN.SW) traded up 3.71 % and now trades at CHF 9.5. Current market capitalisation for Lastminute is CHF 100.6 mn. Lastminute has a current price to earnings ratio of 33.05.

  • Orior (ORON.SW) traded down -2.12 % and now trades at CHF 12.26. Current market capitalisation for Orior is CHF 79.4 mn. Current price/earnings ratio for Orior is 6.27.

  • Curatis (CURN.SW) traded down -4.58 % and now trades at CHF 16.65. Curatis has a market capitalisation of CHF 88.5 mn. Curatis Holding AG, a Swiss biotechnology company listed on the SIX Swiss Exchange, has experienced a decline in its share price during the most recent trading session. The decline was part of a broader movement in the Swiss Market Index, which moved modestly upward in early morning trading before settling near its previous close. Curatis’ shares fell by a small percentage, mirroring the performance of several other mid‑cap stocks in the index that posted modest losses. Analysts noted that the company’s recent valuation and earnings metrics remain consistent with its peers, though the market remains cautious amid broader industry volatility. No significant corporate actions or announcements from Curatis were reported during the period covered.

  • Calida (CALN.SW) traded up 0.75 % and now trades at CHF 13.52. Current market capitalisation for Calida is CHF 93.5 mn. Current price/earnings ratio for Calida is 16.63.

  • Klingelnberg (KLIN.SW) traded up 0.48 % and now trades at CHF 10.55. Current market capitalisation for Klingelnberg is CHF 94.2 mn. Current price/earnings ratio for Klingelnberg is 17.6.

About Bellevue

The Bellevue Group AG is an independent Swiss financial boutique specializing in the asset management business, with its operations headquartered in Kuesnacht. Founded in 1993, their activities have been focused on a selective and diversified range of services across three main areas: specialized healthcare strategies, alternative investment strategies, and traditional investment strategies. Their web address is www.bellevue.ch , and they are listed on the SIX Swiss Exchange.